This inventor holds 1 USPTO granted patent. Top assignee: Cancer Research Campaign Technology Limited. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Patrick Chène
Introduction
Patrick Chène is a notable inventor based in Mulhouse, France. He has made significant contributions to the field of cancer research through his innovative work. His expertise lies in developing assays that can identify inhibitors of critical protein interactions.
Latest Patents
Chène holds a patent for an assay designed to identify inhibitors of the interaction between the proteins p53 and dm2. This invention focuses on a new assay that allows for the identification of compounds that inhibit the formation of complexes between the product of the double minute 2 gene (dm2) and p53, while not affecting the interaction between p53 and DNA. The assay utilizes a gel shift procedure to detect both the complex formation of labeled DNA, C-terminally truncated p53, and dm2, as well as the disruption of dm2 from the labeled DNA-p53 complex by an inhibitor. This innovative approach enables the selection of compounds that inhibit the p53-dm2 interaction without altering p53's specific DNA binding or its conformation necessary for DNA binding or the formation of an active tetramer. Chène's patent is a valuable asset in the ongoing fight against cancer.
Career Highlights
Chène has dedicated his career to advancing cancer research. His work has been instrumental in developing new methodologies that enhance our understanding of protein interactions in cancer biology. His innovative spirit and commitment to research have positioned him as a key figure in his field.
Collaborations
Chène collaborates with Heinz-Kurt Hochkeppel, further enhancing the impact of his research. Their combined expertise contributes to the advancement of cancer research and the development of new therapeutic strategies.
Conclusion
Patrick Chène's contributions to the field of cancer research through his innovative patent demonstrate his commitment to improving therapeutic options. His work continues to inspire advancements in the understanding of protein interactions in cancer biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile